Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

Summary

This is a sequential efficacy and safety study in pediatric patients with type 1 diabetes. Subjects will be administered insulin to induce a low normal glycemic state and will then receive an age-appropriate dose of G-Pen (glucagon injection) in a clinical research center (CRC) or comparable setting.

Timeline

Start

2017-03-27

Primary completion

2017-09-07

Completion

2017-09-27

Drugs

Indications